156 related articles for article (PubMed ID: 6161630)
21. Radiation therapy of testicular non-seminomas.
van der Werf-Messing B; Hop WC
Int J Radiat Oncol Biol Phys; 1982 Feb; 8(2):175-8. PubMed ID: 6177670
[TBL] [Abstract][Full Text] [Related]
22. Factors influencing the survival of patients with testicular teratoma.
Alderdice JM; Merrett JD
J Clin Pathol; 1985 Jul; 38(7):791-6. PubMed ID: 2410461
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors in metastatic nonseminomatous germ cell tumours.
Hanson PR; Belitsky P; Millard OH; Lannon SG
Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
[TBL] [Abstract][Full Text] [Related]
24. Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience.
Aass N; Klepp O; Cavallin-Stahl E; Dahl O; Wicklund H; Unsgaard B; Baldetorp L; Ahlström S; Fosså SD
J Clin Oncol; 1991 May; 9(5):818-26. PubMed ID: 1707957
[TBL] [Abstract][Full Text] [Related]
25. Prognosis in patients with metastatic non-seminomatous testicular cancer.
Aass N; Fosså SD; Ous S; Stenwig AE; Lien HH; Paus E; Kaalhus O
Radiother Oncol; 1990 Apr; 17(4):285-92. PubMed ID: 1693003
[TBL] [Abstract][Full Text] [Related]
26. [Determination of specific markers in the blood in tumors of the testis].
Sakalo VS; Klimenko IA; Iaremko VN; Zaparin VK
Klin Khir (1962); 1990; (5):47-8. PubMed ID: 1697352
[No Abstract] [Full Text] [Related]
27. [Evaluation of serum AFP, HCG, and CEA in testicular tumor].
Miki T; Oda H; Kamei O; Saiki S; Kinouchi T; Kuroda M; Yoshida M; Kiyohara H; Usami M; Osafune M
Nihon Hinyokika Gakkai Zasshi; 1983 Jul; 74(7):1236-47. PubMed ID: 6198548
[No Abstract] [Full Text] [Related]
28. [Studies on the tumor markers in the germinal testicular tumors. Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG) and carcinoembryonic antigen (CEA) in germinal testicular tumors using an indirect immunoperoxidase method].
Miki T
Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):503-22. PubMed ID: 6206269
[No Abstract] [Full Text] [Related]
29. [Diagnosis and therapy of malignant testicular neoplasms].
Douwes FR; Yu D; Truss F
Onkologie; 1978 Oct; 1(5):185-92. PubMed ID: 83558
[TBL] [Abstract][Full Text] [Related]
30. [Tumor marker diagnosis in non-seminomatous testicular tumors using human chorionic gonadotropin (HCG) and alpha fetoprotein (AFP)].
Boewer C; Nawka S; Fleck H; Uibel M; Immer U; Schmidt HE; Herzmann H; Pilgrim G; Ziegenbein R
Z Urol Nephrol; 1985 Feb; 78(2):77-86. PubMed ID: 2581393
[TBL] [Abstract][Full Text] [Related]
31. False-positive and false-negative alpha-feto protein and human chorionic gonadotropin assays in testicular cancer: a double blind study.
Javadpour N; Soares T
Cancer; 1981 Nov; 48(10):2279-81. PubMed ID: 6170418
[TBL] [Abstract][Full Text] [Related]
32. Circulating immune complexes as markers of response to chemotherapy in malignant teratomas and gestational trophoblastic tumours.
Begent RH; Chester KA; Walker LC; Tucker DF
Br J Cancer; 1982 Feb; 45(2):217-22. PubMed ID: 6174138
[TBL] [Abstract][Full Text] [Related]
33. Predicting outcome to chemotherapy in patients with germ cell tumors: the value of the rate of decline of human chorionic gonadotrophin and alpha-fetoprotein during therapy.
Mazumdar M; Bajorin DF; Bacik J; Higgins G; Motzer RJ; Bosl GJ
J Clin Oncol; 2001 May; 19(9):2534-41. PubMed ID: 11331333
[TBL] [Abstract][Full Text] [Related]
34. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
Neumann A; Keller T; Jocham D; Doehn C
Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
[TBL] [Abstract][Full Text] [Related]
35. The role of abdominal surgery in the treatment of advanced testicular germ cell tumours.
Jones BM; Newlands ES; Begent RH; Rustin GJ; Bagshawe KD; Johnson AG; Reynolds KW
Br J Surg; 1982 Jan; 69(1):4-6. PubMed ID: 6172177
[TBL] [Abstract][Full Text] [Related]
36. Accuracy of preoperative staging in stages A and B nonseminomatous germ cell testis tumors.
Rowland RG; Weisman D; Williams SD; Einhorn LH; Klatte EC; Donohue JP
J Urol; 1982 Apr; 127(4):718-20. PubMed ID: 6175771
[No Abstract] [Full Text] [Related]
37. The interpretation of marker protein assays: a critical appraisal in clinical studies and a xenograft model.
Raghavan D; Gibbs J; Nogueira Costa R; Kohn J; Orr AH; Barrett A; Peckham MJ
Br J Cancer Suppl; 1980 Apr; 4():191-4. PubMed ID: 6158975
[TBL] [Abstract][Full Text] [Related]
38. Frequency of serum tumour marker monitoring in patients with non-seminomatous germ cell tumours.
Seckl MJ; Rustin GJ; Bagshawe KD
Br J Cancer; 1990 Jun; 61(6):916-8. PubMed ID: 1695522
[TBL] [Abstract][Full Text] [Related]
39. [Human B-HCG and AFP as biological markers in germinal testicular tumors].
Huertas Mora RA; Larrodera López L; Gómez Matobella I; Cortes Funes H
Rev Esp Oncol; 1984; 31(2):321-30. PubMed ID: 6085865
[TBL] [Abstract][Full Text] [Related]
40. Current concepts in management of testicular tumor.
Javadpour N
Urol Surv; 1978 Jun; 28(3):89-94. PubMed ID: 80873
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
